Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study
| Autor: | Pivot, X., Spano, J.P., Espie, M., Cottu, P., Jouannaud, C., Pottier, V., Moreau, L., Extra, J.M., Lortholary, A., Rivera, P., Spaeth, D., Attar-Rabia, H., Benkanoun, C., Dima-Martinez, L., Esposito, N., Gligorov, J. |
|---|---|
| Zdroj: | In European Journal of Cancer September 2017 82:230-236 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect